The United States Food and Drug Administration (USFDA) has red-flagged Torrent Pharmaceuticals for significant violations of current good manufacturing practice (CGMP) regulations at its Indrad facility in Gujarat. The US health regulator had inspected the facility from April 8 to 16, 2019.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.